Derivatives of reactive oxygen metabolites correlates with high-sensitivity C-reactive protein

Journal of Atherosclerosis and Thrombosis

Volumn 15, Issue 4, 2008, Pages 206-212

  Kamezaki, Fumihiko ^a   Yamashita, Kazuhito ^a   Kubara, Takahiro ^a   Suzuki, Yoshiyuki ^a   Tanaka, Seiya ^a   Kouzuma, Ryouji ^a   Okazaki, Masahiro ^a   Tasaki, Hiromi ^a   Otuji, Yutaka ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

D ROMs; hsCRP; Inflammation; Oxidative stress

Indexed keywords

EID: 56349119887     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.E538     Document Type: Article

References (34)

1. Libby P. Inflammation in atherosclerosis. Nature, 2002; 420:868-874
2. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, and Maseri A: The prognostic value of C-reactive protein and strum amyloid a protein in severe unstable angina. N Engl J Med, 1994; 331:417-424
3. Ridker PM: High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation, 2001; 103:1813-1818
4. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, and Hennekens CH: Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med, 1997; 336:973-979
5. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 5rd, Criqui M, Fadl YY, Fortmann SP. Hong Y, Myers GL, Rifai N, Smith SC Jr., Taubert K, Tracy., RP, and Vinicor F: Markers of inflammlation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation, 2003; 107:459-511
6. Walter MF, Jacob RF, Jeffers B, Ghadanfar MM, Preston GM, Buch J, and Mason RP: Serum levels of thiobarbituric acid reactive substances predict cardiovascular events in patients with stable coronary artery disease: a longitudinal analysis of the PREVENT study. J Am Coll Cardiol, 2004; 44:1996-2002
7. Shimada K, Mokuno H, Matsunaga E, Miyazaki T, Sumiyoshi K, Miyauchi K, and Daida H: Circulating oxidized low-density lipoprotein is an independent predictor for cardiac event in patients with coronary artery disease, Atherosclerosis, 2004; 174:343-347
8. Schwedhelm E, Bartling A, Lenzen H, Tsikas D, Maas R, Brümmer J, Gutzki FM, Berger J, Frölich JC, and Böger RH: Urinary 8-iso-prostaglandin F2 alpha as a risk m arker in patients with coronary heart diseases: a matched case-control study. Circulation, 2004; 109:843-848
9. Cesarone MR, Belcaro G, Carratelli M, Cornelli U, De Sanctis MT Incandela L, Barsotti A, Terranova R, and Nicolaides A: A simple test to monitor, oxidative stress. Int Angiol, 1999; 18:127-130
10. Cockcroft DW and Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron, 1976; 1631-41
11. Gensini GG: Coronary arteriography. NY: Futura Publishing Co.; 1975, p.261
12. Bertuglia S and Giusti A Microvascular oxygenation, oxidative stress, NO suppression and superoxide dismutase during postischemic reperfusion. Am J Physiol Heart Circ Physiol, 2003; 285:H1064-1071
13. Bertuglia S and Giusti A: Role of nitric oxide in capillary perfusion and oxygen delivery regulation during systemic hypoxia. Am J Physiol Heart Circ Physiol, 2005; 288:H525-531
14. Gerardi G, Usberti M, Martini G, Albertini A, Sugherini L, Pompella A, and Di LD: Piasm a total antioxidant capacity in hemodialyzed patients and its relationships to other biomarkers of omidative stress and lipid peroxidation. Clin Chem Lab Med, 2002; 40:104-110
15. Cornelli U, Cornelli M, and Terranova R: Free-radical and vascular diseases. The International Union of Angiology's Bulletin, 1999; 157-10
16. Incandela L, Belcaro G, Cesarone MR, De Sanctis MT, Griffin M, Cacchio M, Nicolaides AN, Bucci M, Barsotti A, Martines G, Cornelli U, and Di Renzo A: Oxygen-free radical decrease in hypertensive patients treated with lercanidipine. Int Angiol, 2001; 20:136-140
17. Wang B, Pan J, Wang L, Zthu H, Yu R, and Zou Y: Associations of plasma 8-isoprostane levels with the presence and extent of coronary stenosis in patients with coronary artery disease. Atherosclerosis, 2006; 184:425-430
18. Vassalle C. Botto N, Andrtassi MG, Berti S, and Biagini A: Evidence for enhanced 8-isoprostane plasma levels, as index of oxidative stress in vivo, in patients with coronary artery disease. Coron Artery Dis, 2003; 14:213-218
19. Sakuma N, Hibino T, Sato T, Ohte N, Akita S, Tamai N, Sasai K, Yoshimata. T, and, Fujinami T: Levels of thiobarbituric acid-reactive: substance in plasma from coronary artery disease patients. Clin Biochem, 1997; 30:505-507
20. Inoue T, Kato T, Uchida T, Sakuma M, Nakajima A, Shibazaki M, Imoto Y, Saito M, Hashimoto S, Hikichi Y, and Note K: Local release of C-reactive protein from vulnerable plaque or coronary arterial wall injured by stenting. J Am Coll Cardiol, 2005; 46:239-245
21. Avanzas P, Arroyo-Espliguero R, Cosín-Sales J, Aldama G, Pizzi C, Quile, J, and Kaski JC: Markers of inflammation and multiple complex stenoses (pancoronary plaque vulnerability) in patients with non-ST segment elevation acute coronary syndromes. Heart, 2004; 90:847-852.
22. Griendling KK and FitzGerald GA: Oxidative stress and cardiovascular injury: Part II: animal and human studies. Circulation, 2003; 108:2034-2040
23. Harrison D, Griendling KK, Landmesser U, Hornig B, and Drexler H: Role of oxidative stress in atherosclerosis. Am J Cardiol, 2003; 91:7A-11A
24. Ridker PM: Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation, 2003, 107:363-369
25. Venugopal SK, Dovaraj S, and Jialal I: Macrophage conditioned medium induces the expression of C-reactive protein in human aortic endothelial cells: potential for paracrine/autocrine effects. Am J Pathol, 2005; 166:1265-1271
26. Yasojima K, Schwab C, McGeer EG, and McGeer PL: Generation of C-reactive protein and complement components in atherosclerotic plaques. Am J Pathol, 2001; 158:1039-1051
27. Chang MK, Binder CJ, Torzewski M, and Witz-tum JL C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids. Proc Natl Acad Sci USA, 2002, 99:13043-13048
28. Kobayashi S, Inoue N, Ohashi Y, Terashima M, Matsui K, Mori T, Fujita H, Awano K, Kobayashi K, Azumi H, Ejiri J, Hirata K, Kawashima S, Hayashi Y, Yokozaki H, Itoh H, and Yokoyama M: Interaction of oxidative stress and Inflammatory response in coronary plaque instability: important role of C-reactive protein. Arterioscler Thromb Vasc Biol, 2003; 23:1398-1404
29. Anzai T, Yoshikawa T, Shiraki H, Asakura Y, Akaishi M, Mitamura H, and Ogawa & C-reactive protein as a predictor of infarct expansion and cardiac rupture after afirst Q-wave acute myocardial infarction. Circulation, 1997; 96:778-784
30. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A. Love GD, Pepys MB, and Gudnason V: C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N EnglJ Med, 2004; 350:1387-1397
31. Ridker PM, Hennekens CH, Buring JE, and Rifai N: C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med, 20003 342:836-843
32. Ridker PM, Rifai N, Rose L, Buring JE, and Cook NR: Comparison of C-rcactive. protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med, 2002; 347:1557-1565
33. Albert MA, Glynn RJ, and Ridker PM: Alcohol consumption and plasma concentration of C-reactive protein. Circulation, 2003; 107:443-447
34. Meagher EA, Barry OF, Burke A, Lucey MR, Lawson JA, Rokach J, and FitzGerald GA: Alcohol-induced generation of lipid peroxidation products in humans. J Clin Invest, 1999; 104:805-813